News - Lymphoma Canada

Events News

Spaghetti sauce for lymphoma

Nick was diagnosed with non Hodgkin's Lymphoma in September 2013. Once treated and in remission,…

adminOctober 2, 2017

News

CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA

CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA -- Province’s investment…

adminSeptember 27, 2017

News

Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo)

Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo) If you have or had Hodgkin lymphoma…

adminSeptember 19, 2017

Events News

Count Down to World Lymphoma Awareness Day

#EverythingChanges for World Lymphoma Awareness Day No one ever expects to sit in the doctor’s…

adminSeptember 6, 2017

News

Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris)

Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris) If you have or had Hodgkin lymphoma…

adminJuly 26, 2017

News

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin…

adminJuly 26, 2017

Events News

Lymphoma Canada Awareness Day at Queen’s Park

Lymphoma Canada Awareness Day at Queen's Park Cocktail reception 5:00 p.m. – 7:00 p.m. Guests must…

adminJuly 19, 2017

News

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

Treatment with a new targeted therapy, duvelisib, has shown sustained efficacy and safety in a…

adminJuly 7, 2017

News

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

Treatment with a new targeted therapy, duvelisib, has shown sustained efficacy and safety in a…

adminJuly 7, 2017

News

Manitoba Leads the Way in CLL Research and Treatment

Recently, a group of Manitoba CLL experts formed the Integrated Multidisciplinary CLL Research Cluster –…

adminJuly 7, 2017

Mon	Tue	Wed	Thu	Fri	Sat	Sun
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28

News & Media

Spaghetti sauce for lymphoma

CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA

Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo)

Count Down to World Lymphoma Awareness Day

Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris)

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression

Lymphoma Canada Awareness Day at Queen’s Park

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

Manitoba Leads the Way in CLL Research and Treatment

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Join Our Mailing List